Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles
The global innovative drug "hard power" leads the way, Danuo Medicine-B (06872) opens the IPO to explore the anti-infection track.
On May 15, CHINA STARCH (03838) spent 551,000 Hong Kong dollars to repurchase 3 million shares.
Feihe (06186) deciphers the early life intestinal microbiota code, ushering in a new era of precise nutrition for infants and young children.
The global innovative drug "hard power" leads the way, Danuo Medicine-B (06872) opens the IPO to explore the anti-infection track.
On May 15, CHINA STARCH (03838) spent 551,000 Hong Kong dollars to repurchase 3 million shares.
Feihe (06186) deciphers the early life intestinal microbiota code, ushering in a new era of precise nutrition for infants and young children.
